In this issue:
- Endocrine therapy for male breast cancer
- Mindfulness-based interventions
- Menopausal symptoms, sexual problems, and mood disturbances
- Introducing SentiMag in a rural setting
- Margin width and local recurrence after neoadjuvant chemotherapy
- Duration of adjuvant aromatase inhibitor therapy
- Real time remote symptom monitoring
- Adjuvant olaparib for patients with BRCA1/2 mutations
- Adjuvant pertuzumab and trastuzumab in early HER2+ breast cancer
- Niraparib for aBC with germline BRCA1/2 mutations
Please login below to download this issue (PDF)